DDX50 Inhibits the Replication of Dengue Virus 2 by Upregulating IFN-β Production

Peijun Han,Wei Ye,Xin Lv,Hongwei Ma,Daihui Weng,Yangchao Dong,Linfeng Cheng,Hesong Chen,Liang Zhang,Zhikai Xu,Yingfeng Lei,Fanglin Zhang
DOI: https://doi.org/10.1007/s00705-017-3250-3
IF: 2.685
2017-01-01
Archives of Virology
Abstract:Dengue virus (DENV) infects approximately 390 million people per year, and each of the four DENV serotypes (DENV-1, DENV-2, DENV-3, and DENV-4) is capable of causing infection. At present, there is no antiviral drug available for the treatment of DENV. Several DExD/H-box helicases have been shown to be involved in the antiviral immune response or viral replication. In the present study, we investigated the role of DDX50 in DENV-2 RNA replication. Our data showed that the level of DENV-2 RNA increased in DDX50 knockdown cells during an early stage of viral infection and decreased in DDX50-overexpressing cells. DDX50, in conjunction with RIG-I and MDA5, upregulated the production of IFN-β in infected cells through an additive effect on the IFN-β promoter. Furthermore, transcription of several IFN-stimulated genes was increased in DDX50-overexpressing cells infected with DENV-2. These results provide evidence that DDX50 negatively regulates DENV-2 replication during the early stages of infection by inducing IFN-β production.
What problem does this paper attempt to address?